- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02022410
CAS and Length of Hospital Stay After TKA
Cumulated Ambulation Score and Length of Hospital Stay After TKA
Study Overview
Detailed Description
The number of patients who receive a total knee arthroplasty (TKA) is steadily increasing and although the reliability and the results of this procedure are excellent, intensive functional rehabilitation is needed postoperatively to obtain satisfactory range of motion. Currently, the standard length of stay at our hospital is between 8 and 10 days for patients who undergo TKA.
The length of stay depends not only on factors such as early mobilization, pain management, major or minor complications and logistical or organizational problems (1) (2). It also depends on the availability of adequate services when the patient needs to be transferred to an appropriate facility. Each of these steps can be further developed in order to improve the quality of care for patients, reduce hospital costs and increase the availability of beds (3). As a result, the reduction in average length of stay would not only result in a reduction in cost but also a greater turnover in the number of patients. Several studies show that the application of a post-operative fast-track strategy may reduce the length of stay in a very significant manner with benefit for patients and hospitals (3).Thus, if their condition allows, patients would have rapid post-operative rehabilitation, with early joint mobilization at D0 (operative day) and walking from D1 (the first post-operative day).
The Cumulated Ambulation Score (CAS) (4) is a tool developed and tested for initial predicting the in-patient length of stay following a hip surgery. The CAS consists of documenting the patient's ability and independence while performing 3 basic daily activities (sit to stand, transfer out of bed and mobilization). It is calculated using a score of 0-2 for each parameter, giving a total daily score of 0 to 6 and a score of 0 to 18 during the first 3 post-operative days. The CAS is then the sum of scores of the first 3 post-operative days. This score proves to be an effective tool for predicting the length of stay, and other parameters investigated such as survival rate and return home after a proximal femoral surgery.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1011
- CHUV - Hopital Orthopedique
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria: Adults after elective TKA -
Exclusion Criteria: No consent form signed, neurological impairment
-
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CAS after primary and revision TKA
CAS and RAPT
|
CAS and RAPT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CAS value
Time Frame: The 3rd day after TKA
|
Record the CAS values for the first three operative days as mentioned in the protocol
|
The 3rd day after TKA
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of stay
Time Frame: between 4 days and 2 weeks
|
Record number of in-hospital days
|
between 4 days and 2 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Destination at the end of the hospitalisation
Time Frame: at the moment of departure from in-hospital care
|
Record the patients' destination at the end of the in-hospital stay: home, rehabilitation centre, residential home or other.
|
at the moment of departure from in-hospital care
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: B Jolles, Prof., CHUV
- Principal Investigator: Luís C Pereira, MSc, CHUV
- Principal Investigator: Georgios Gkagkalis, Dr, CHUV
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CHUV 144/13
- CaS (DAL TKA registry)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CAS
-
Chang Gung Memorial HospitalCompletedPatients With Osteoarthritis Undergoing CAS-TKA
-
University of Southern DenmarkRegion of Southern Denmark; OPEN; Lida og Oskar Nielsens Fond; Esbjerg Fonden; Gangsted...Completed
-
RECORDATI GROUPActive, not recruitingCold Agglutinin Disease (CAD) | Cold Agglutinin Syndrome (CAS)United States, Austria, France, Germany, Italy, Japan, Spain, United Kingdom
-
University of ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsActive, not recruitingDialysis | End Stage Renal Disease (ESRD) | Brachiocephalic Fistula (BCF) | Cephalic Arch Stenosis (CAS)United States
Clinical Trials on CAS after primary and revision TKA
-
Hospices Civils de LyonStryker NordicCompletedKnee Arthroplasty, Total | Gait AnalysisFrance
-
Rush University Medical CenterMayo ClinicCompletedRevision Total Knee Arthroplasty | Revision Total Hip Arthroplasty | Acute Blood Loss AnemiaUnited States
-
Laura Belinda RizzoUniversità degli Studi 'G. d'Annunzio' Chieti e PescaraCompletedArthrosis of the KneeItaly
-
Leiden University Medical CenterAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Onze Lieve...CompletedOsteoarthritis, Knee | Psychological Stress | Mental StressNetherlands
-
Mario Negri Institute for Pharmacological ResearchCompletedColorectal Cancer | Surveillance
-
University Hospital Schleswig-HolsteinCompleted
-
Tokyo Medical and Dental UniversityRecruitingBreast Cancer | Metastatic Breast Cancer | OligometastasisJapan
-
Assiut UniversityNot yet recruitingRate of Infection After Using Antibiotic Loaded Cement and Regular Cement in Total Knee ArthroplastyPrimary Osteoarthritis of Knee Nos
-
Luzerner KantonsspitalCompletedInfection Rates Between Primary Wound-closure (Allgower) and Secondary Wound Healing After Removal of an External FixatorSwitzerland
-
GlaxoSmithKlineCompleted